| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.008 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.085 | 0.009 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |